41S RIO GRANDE STREET, SALT LAKE CITY, UT
Market cap: $1.5B (2/09/2026)
Price: $3.85
Investor Presentation
Recursion Pharmaceuticals Files Prospectus Supplement for 7,088,742 Shares
Reports Third Quarter 2025 Financial Results and Provides Business Update
Other Events
Amended material disclosure
Reports Second Quarter 2025 Financial Results and Provides Business Update
Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)